[Evaluation of the activity of p-chlorophenoxyacetic acid isopropylhydrazide (Sinderesin) in the treatment of coronary insufficiency].
D015084:2,4-Dichlorophenoxyacetic Acid / Q000031:analogs & derivatives; D003324:Coronary Artery Disease; D003327:Coronary Disease; D006801:Humans; D008996:Monoamine Oxidase Inhibitors; D014665:Vasodilator Agents
D008996:Monoamine Oxidase Inhibitors; D014665:Vasodilator Agents; D015084:2,4-Dichlorophenoxyacetic Acid; C007017:4-chlorophenoxyacetic acid
CORONARY DISEASE; MONOAMINE OXIDASE INHIBITORS; VASODILATOR AGENTS